- Home
- PLBL vs RXRX Comparison
PLBL vs RXRX Comparison
Compare PLBL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLBL | RXRX |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLBL | RXRX |
|---|---|---|
| Price | $5.43 | $3.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $7.32 |
| AVG Volume (30 Days) | 176.2K | ★ 25.0M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $5.10 | $2.77 |
| 52 Week High | $11.75 | $6.50 |
Technical Indicators
Market Signals| Indicator | PLBL | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 45.16 |
| Support Level | $5.25 | $2.90 |
| Resistance Level | $5.91 | $3.88 |
| Average True Range (ATR) | 0.28 | 0.45 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 23.66 | 5.43 |
Price Performance
Historical ComparisonAbout PLBL Polibeli Group Ltd Class A Ordinary Shares
Polibeli Group Ltd is a holding company without any business operations. It provides digital supply chain services and distribution sales through subsidiaries in a number of countries around the globe. Currently, its business is mainly in Japan and Indonesia, while also having business operations in some international locations, including Hong Kong, Europe, and Others. The single reportable segment contains product revenues derived from world-wide goods trading, and service revenues that are ancillary to world-wide goods trading business.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.